EUVIMEDEUVIMED entdecken
Open Access

ALPS ‐ HCC Score: A Dynamic Liver Stiffness Measurement‐Based Machine Learning Model to Predict Risk of Hepatocellular Carcinoma

Yinan Huang, Hongsheng Yu iD, Bilan Yang, Hao Jiang iD, Can Hu, Qinling Yu iD, Xiaoli Xi, Mingkai Li iD, Yiming Lei, Bin Wu iD, Biao Xie, Huiguo Ding iD und 1 weitere

Liver International · 2026

DOI: 10.1111/liv.70866 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2026. Verfasst von Yinan Huang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hepatitis B, Chronic, Machine Learning. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Science Fund for Distinguished Young Scholars of Guangdong Province, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims Existing hepatocellular carcinoma (HCC) risk scores specific to chronic hepatitis B (CHB) mostly rely solely on baseline indicators, limiting their applicability in clinical practice. By incorporating dynamic and static indicators, this study aimed to address this limitation by developing a machine learning (ML) model for HCC prediction in patients with CHB and compensated advanced chronic liver disease (cACLD).

Methods

ML models were trained to predict HCC in 1 272 patients with CHB and cACLD, who underwent at least 2 measurements from different centres and were further tested with external cohorts ( n = 601). The first and last liver stiffness measurements were defined as the baseline and follow‐up values, respectively.

Results

A total of 1 873 individuals with CHB and cACLD were included, with 192 patients (10.3%) developing HCC after a median of 30.7 months. Based on LASSO logistic regression, baseline age, baseline albumin concentration, follow‐up albumin concentration, follow‐up platelet count, and change in the liver stiffness measurement (∆LSM) were selected, with ∆LSM identified as the most important indicator. Developed using XGBoost, the ALPS‐HCC score achieved the highest integrated AUROC (0.852), Harrell's C‐index (0.852), and F1 score (0.944), and performed significantly better than existing HCC risk scores. Based on these results, our risk stratification performed well in terms of prognosis in the validation cohort, including the identification of low‐risk ( n = 250; reference), intermediate‐risk ( n = 91; hazard ratio [HR] = 5.25), and high‐risk ( n = 41; HR = 24.47) groups.

Conclusions

ALPS‐HCC score provides robust predictive power and screening capability for predicting HCC risk in patients with CHB and cACLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHepatitis B, ChronicMachine LearningLiverHumansFemalePredictive Learning ModelsMaleMiddle AgedElasticity Imaging TechniquesRisk AssessmentAdultRisk FactorsBoosting Machine Learning AlgorithmsLogistic ModelsROC CurvePredictive Value of Tests

Stichwörter der Autor:innen

compensated advanced chronic liver diseasehepatocellular carcinomaliver fibrosismachine learningtransient elastography

Autor:innen und Institutionen

  • Department of Gastroenterology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Guangdong Provincial Key Laboratory of Liver Disease Research, Guangzhou, China.
  • Department of Gastroenterology, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
  • Department of Gastroenterology and Hepatology, Laboratory for Clinical Medicine, Beijing You'an Hospital Affiliated to Capital Medical University, Beijing, China.
  • Department of Gastroenterology, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
  • Department of Gastroenterology, The Third Affiliated Hospital of Sun Yat-Sen University Lingnan Hospital, Guangzhou, China.

ORCID-Profile: Hongsheng Yu, Hao Jiang, Qinling Yu, Mingkai Li, Bin Wu, Huiguo Ding, Yidong Yang

Förderung

  • Science Fund for Distinguished Young Scholars of Guangdong Province
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Huang, Y., Yu, H., Yang, B., Jiang, H., Hu, C., Yu, Q., Xi, X., Li, M., Lei, Y., Wu, B., Xie, B., Ding, H., & Yang, Y. (2026). ALPS ‐ HCC Score: A Dynamic Liver Stiffness Measurement‐Based Machine Learning Model to Predict Risk of Hepatocellular Carcinoma. Liver International. https://doi.org/10.1111/liv.70866

Vancouver

Huang Y, Yu H, Yang B, Jiang H, Hu C, Yu Q, et al. ALPS ‐ HCC Score: A Dynamic Liver Stiffness Measurement‐Based Machine Learning Model to Predict Risk of Hepatocellular Carcinoma. Liver International. 2026. doi:10.1111/liv.70866

BibTeX
@article{Huang2026,
  author = {Huang, Yinan and Yu, Hongsheng and Yang, Bilan and Jiang, Hao and Hu, Can and Yu, Qinling and Xi, Xiaoli and Li, Mingkai and Lei, Yiming and Wu, Bin and Xie, Biao and Ding, Huiguo and Yang, Yidong},
  title = {ALPS ‐ HCC Score: A Dynamic Liver Stiffness Measurement‐Based Machine Learning Model to Predict Risk of Hepatocellular Carcinoma},
  journal = {Liver International},
  year = {2026},
  doi = {10.1111/liv.70866}
}
Kostenlos starten →